Original articleA new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆
References (13)
The pre-therapeutic classification of co-morbidity in chronic disease
J Chron Dis
(1970)- et al.
The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus
J Chron Dis
(1974) - et al.
Assessing illness severity: Does clinical judgment work?
J Chron Dis
(1986) - et al.
Maximum utilization of the life table method in analyzing survival
J Chron Dis
(1958) - et al.
Applying results of randomised trials to clinical practice: Impact of losses before randomization
Br Med J
(1984) - et al.
Controversy in counting and attributing events in clinical trials
N Engl J Med
(1979)
There are more references available in the full text version of this article.
Cited by (38620)
Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort
2024, BMC Medical Research MethodologyPrognostic factors of renal cell cancer in elderly patients: a population-based cohort study
2024, Scientific ReportsSocietal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey
2024, Journal of Headache and Pain
- ☆
Presented in part at the American Federation for Clinical Research, Washington, D.C., 3–5 May 1986.
- ∗
Dr Charlson is a Henry J. Kaiser Family Foundation Faculty Scholar in General Internal Medicine.
Copyright © 1987 Published by Elsevier Inc.